OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺素释放因子治疗相关副作用是常见，重到足以停药程度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺，与第一代多巴胺不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺素释放因子治疗相关的副作用是常见的，到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺剂，与第一代多巴胺剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺，与第一代多巴胺不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常，严重到足以停药程度是罕。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺激，与第一代多巴胺激不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗副作用是常见，但严重到足以停药程度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺激，与第一代多巴胺激不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动临床应疗性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期性腺激素释放因子治疗相关的副常见的，但严重到足以停药的程度罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗一种类似多巴胺的多巴胺激动，与第一代多巴胺激动不同的没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺的多巴胺激动剂，与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常见，但严重到足以停度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴胺多巴胺激动剂，与第一代多巴胺激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴胺D2受体有较高结合力。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效性。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常见，但严重到足以停药程度是罕见。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似巴胺巴胺激动剂，与第一代巴胺激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与巴胺D2受体有较高结合力。